These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22952382)

  • 1. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.
    Vargas HA; Akin O; Shukla-Dave A; Zhang J; Zakian KL; Zheng J; Kanao K; Goldman DA; Moskowitz CS; Reuter VE; Eastham JA; Scardino PT; Hricak H
    Radiology; 2012 Nov; 265(2):478-87. PubMed ID: 22952382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.
    Weinreb JC; Blume JD; Coakley FV; Wheeler TM; Cormack JB; Sotto CK; Cho H; Kawashima A; Tempany-Afdhal CM; Macura KJ; Rosen M; Gerst SR; Kurhanewicz J
    Radiology; 2009 Apr; 251(1):122-33. PubMed ID: 19332850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
    Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
    Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications.
    Vargas HA; Akin O; Franiel T; Goldman DA; Udo K; Touijer KA; Reuter VE; Hricak H
    Radiology; 2012 Mar; 262(3):894-902. PubMed ID: 22357889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
    Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
    Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
    Turkbey B; Pinto PA; Mani H; Bernardo M; Pang Y; McKinney YL; Khurana K; Ravizzini GC; Albert PS; Merino MJ; Choyke PL
    Radiology; 2010 Apr; 255(1):89-99. PubMed ID: 20308447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume.
    Jung SI; Jeon HJ; Park HS; Yu MH; Kim YJ; Lee SE; Lim SD
    Br J Radiol; 2018 Jun; 91(1086):20180001. PubMed ID: 29493284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
    Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
    Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard.
    Arumainayagam N; Ahmed HU; Moore CM; Freeman A; Allen C; Sohaib SA; Kirkham A; van der Meulen J; Emberton M
    Radiology; 2013 Sep; 268(3):761-9. PubMed ID: 23564713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.
    Jung SI; Donati OF; Vargas HA; Goldman D; Hricak H; Akin O
    Radiology; 2013 Nov; 269(2):493-503. PubMed ID: 23878284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
    Lim HK; Kim JK; Kim KA; Cho KS
    Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.
    Fütterer JJ; Engelbrecht MR; Huisman HJ; Jager GJ; Hulsbergen-van De Kaa CA; Witjes JA; Barentsz JO
    Radiology; 2005 Nov; 237(2):541-9. PubMed ID: 16244263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study.
    Hoang Dinh A; Melodelima C; Souchon R; Lehaire J; Bratan F; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O
    Radiology; 2016 Jul; 280(1):117-27. PubMed ID: 26859255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
    Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H
    Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.
    Dhingsa R; Qayyum A; Coakley FV; Lu Y; Jones KD; Swanson MG; Carroll PR; Hricak H; Kurhanewicz J
    Radiology; 2004 Jan; 230(1):215-20. PubMed ID: 14695396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How accurate is multiparametric MR imaging in evaluation of prostate cancer volume?
    Bratan F; Melodelima C; Souchon R; Hoang Dinh A; Mège-Lechevallier F; Crouzet S; Colombel M; Gelet A; Rouvière O
    Radiology; 2015 Apr; 275(1):144-54. PubMed ID: 25423145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer.
    Barrett T; Vargas HA; Akin O; Goldman DA; Hricak H
    Radiology; 2012 Jun; 263(3):751-7. PubMed ID: 22474673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
    Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
    Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.